The goal of this project is to develop a range of techniques to study drug transport across biological barriers. A continuum of techniques from in vitro model systems through in vivo animal systems will be developed. The techniques will be based on a combination of microdialysis sampling and capillary electrophoresis. These techniques will provide methods for high throughput screening in early drug development that will be correlated to in vivo studies. A high throughput method based on vesicular and cell-modified capillary electrophoresis (CE) will be developed. In this technique, vesicles, either artificial or biologically derived, or cells will be used as migration modifiers in CE. Partitioning of the test compounds into the vesicles or cells will modify the migration of the test compounds based on their permeability into the vesicle or cell. The change in migration relative to normal CE should correlate to membrane permeability. This approach will provide high throughput by allowing simultaneous permeability determinations of compounds in a mixture. We will also develop in vivo microdialysis techniques using cell culture models of biological barriers. The diffusion cell approach to using cell culture models to determine permeability will be modified by growing the cells on microdialysis probes. This will improve the throughput of cell culture techniques by improving the mass transport in the system. In addition, the continuous sampling capabilities of microdialysis will provide for kinetic determinations as well as equilibrium measurements. Cell-coated microdialysis probes will also be reusable. Finally, work will continue on the in vivo studies using microdialysis sampling to study transport across biological barriers in vivo. The focus will be on transport across the gastro-intestinal mucosa, across the placenta, and across the blood-brain-barrier. The same set of test compounds will be used in all of the in vitro and in vivo studies to provide an in vitro to in vivo correlation. The development of these methods will also provide a continuum of techniques of increasing complexity but decreasing throughput.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM044900-11
Application #
6386024
Study Section
Special Emphasis Panel (ZRG1-BMT (01))
Program Officer
Okita, Richard T
Project Start
1991-06-01
Project End
2004-05-31
Budget Start
2001-06-01
Budget End
2002-05-31
Support Year
11
Fiscal Year
2001
Total Cost
$148,927
Indirect Cost
Name
University of Kansas Lawrence
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
072933393
City
Lawrence
State
KS
Country
United States
Zip Code
66045
Weiss, D J; Saunders, K; Lunte, C E (2001) pH-mediated field-amplified sample stacking of pharmaceutical cations in high-ionic strength samples. Electrophoresis 22:59-65
Razak, J L; Cutak, B J; Larive, C K et al. (2001) Correlation of the capacity factor in vesicular electrokinetic chromatography with the octanol:water partition coefficient for charged and neutral analytes. Pharm Res 18:104-11
Osboum, D M; Lunte, C E (2001) Cellulose acetate decoupler for on-column electrochemical detection in capillary electrophoresis. Anal Chem 73:5961-4
Gilinsky, M A; Faibushevish, A A; Lunte, C E (2001) Determination of myocardial norepinephrine in freely moving rats using in vivo microdialysis sampling and liquid chromatography with dual-electrode amperometric detection. J Pharm Biomed Anal 24:929-35
McLaughlin, K J; Faibushevich, A A; Lunte, C E (2000) Microdialysis sampling with on-line microbore HPLC for the determination of tirapazamine and its reduced metabolites in rats. Analyst 125:105-10
Osbourn, D M; Weiss, D J; Lunte, C E (2000) On-line preconcentration methods for capillary electrophoresis. Electrophoresis 21:2768-79
Davies, M I; Cooper, J D; Desmond, S S et al. (2000) Analytical considerations for microdialysis sampling. Adv Drug Deliv Rev 45:169-88
Ye, M; Rossi, D T; Lunte, C E (2000) Microdialysis sampling of the isothiazolone, PD-161374, and its thiol and disulfide metabolites. J Pharm Biomed Anal 24:273-80
Weiss, D J; Lunte, C E (2000) Detection of a urinary biomaker for oxidative DNA damage 8-hydroxydeoxyguanosine by capillary electrophoresis with electrochemical detection. Electrophoresis 21:2080-5
Hansen, D K; Davies, M I; Lunte, S M et al. (1999) Pharmacokinetic and metabolism studies using microdialysis sampling. J Pharm Sci 88:14-27

Showing the most recent 10 out of 22 publications